Evidence map›Paper›PMID 36312282›Full record

ArticleFrontiers in cardiovascular medicine2022

Activation of cannabinoid receptor 2 attenuates Angiotensin II-induced atrial fibrillation

Dengyue Xu, Chennian Xu, Xiaodong Xue, Yinli Xu, Jikai Zhao, Tao Huang, Zhishang Wang, Qiusheng Zhao, Zijun Zhou, Yuting Huang and 2 more

Abstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Dengyue XuDepartment of Cardiovascular Surgery, General Hospital of Northern Theater Command, Shenyang, Liaoning, China.
Chennian XuDepartment of Cardiovascular Surgery, General Hospital of Northern Theater Command, Shenyang, Liaoning, China.
Xiaodong XueDepartment of Cardiovascular Surgery, General Hospital of Northern Theater Command, Shenyang, Liaoning, China.
Yinli XuDepartment of Cardiovascular Surgery, General Hospital of Northern Theater Command, Shenyang, Liaoning, China.
Jikai ZhaoDepartment of Cardiovascular Surgery, General Hospital of Northern Theater Command, Shenyang, Liaoning, China.
Tao HuangDepartment of Cardiovascular Surgery, General Hospital of Northern Theater Command, Shenyang, Liaoning, China.
Zhishang WangDepartment of Cardiovascular Surgery, General Hospital of Northern Theater Command, Shenyang, Liaoning, China.
Qiusheng ZhaoDepartment of Cardiovascular Surgery, General Hospital of Northern Theater Command, Shenyang, Liaoning, China.
Zijun ZhouDepartment of Cardiovascular Surgery, General Hospital of Northern Theater Command, Shenyang, Liaoning, China.
Yuting HuangDepartment of Cardiovascular Surgery, General Hospital of Northern Theater Command, Shenyang, Liaoning, China.
Liming YuDepartment of Cardiovascular Surgery, General Hospital of Northern Theater Command, Shenyang, Liaoning, China.
Huishan WangDepartment of Cardiovascular Surgery, General Hospital of Northern Theater Command, Shenyang, Liaoning, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Atrial fibrillation (AF) is the most frequent arrythmia managed in clinical practice. Several mechanisms have been proposed to contribute to the occurrence and persistence of AF, in which oxidative stress plays a non-negligible role. The endocannabinoid system (ECS) is involved in a variety physiological and pathological processes. Cannabinoid receptor 1 (CB1R) and cannabinoid receptor 2 (CB2R) are expressed in the heart, and studies have shown that activating CB2R has a protective effect on the myocardium. However, the role of CB2R in AF is unknown. Materials and methods: Angiotensin II (Ang II)-infused mice were treated with the CB2R agonist AM1241 intraperitoneally for 21 days. Atrial structural remodeling, AF inducibility, electrical transmission, oxidative stress and fibrosis were measured in mice. Results: The susceptibility to AF and the level of oxidative stress were increased significantly in Ang II-infused mice. In addition, nicotinamide adenine dinucleotide phosphate oxidase 2 (NOX2), NOX4, and oxidized Ca Conclusion: The present study demonstrates that pharmacological activation of CB2R exerts a protective effect against AF

Indexed as

atrial fibrillationCa2+/calmodulin-dependent protein kinase IIcannabinoid receptor 2endocannabinoid systemnicotinamide adenine dinucleotide phosphate oxidaseoxidative stress

Identifiers

PMID36312282
PMCPMC9616165

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.